Cytokinetics bags milestone as Amgen starts CVOT

Cytokinetics Inc. (NASDAQ:CYTK) said partner Amgen Inc. (NASDAQ:AMGN) started the Phase III GALACTIC-HF study

Read the full 143 word article

User Sign In